Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (371-380 of 664) with videos related to

Pageof 67
Sort By:
Cancer|December 14, 2011
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinomaSarah Minner, Dorothea Rump, Pierre Tennstedt, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Future Oncology (London, England)|October 18, 2023
Cetuximab every 2 weeks versus standard weekly dosing administration scheduleCarsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cellsMirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
Thrombosis and Haemostasis|June 4, 2009
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancerKatja Haubold, Michael Rink, Brigitte Spath, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Aktuelle Urologie|September 24, 2020
[CARD study: relevance for the treatment of advanced prostate cancer]Axel S Merseburger, Andreas Bannowsky, Klaus Becker, et al.
Cells|March 25, 2022
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian CancerPauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.
Journal of Clinical Pathology|May 29, 2012
PTEN deletion is rare but often homogeneous in gastric cancerSormeh Mina, Benjamin A Bohn, Ronald Simon, et al.
Plos One|January 18, 2013
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitorsStefan Balabanov, Thomas Wilhelm, Simone Venz, et al.
Pageof 67

Showing results (371-380 of 664) with videos related to

Sort By:
Pageof 67
Cancer|December 14, 2011
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinomaSarah Minner, Dorothea Rump, Pierre Tennstedt, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Future Oncology (London, England)|October 18, 2023
Cetuximab every 2 weeks versus standard weekly dosing administration scheduleCarsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cellsMirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
Thrombosis and Haemostasis|June 4, 2009
Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancerKatja Haubold, Michael Rink, Brigitte Spath, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Aktuelle Urologie|September 24, 2020
[CARD study: relevance for the treatment of advanced prostate cancer]Axel S Merseburger, Andreas Bannowsky, Klaus Becker, et al.
Cells|March 25, 2022
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian CancerPauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.
Journal of Clinical Pathology|May 29, 2012
PTEN deletion is rare but often homogeneous in gastric cancerSormeh Mina, Benjamin A Bohn, Ronald Simon, et al.
Plos One|January 18, 2013
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitorsStefan Balabanov, Thomas Wilhelm, Simone Venz, et al.
Pageof 67